Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Windtree Therapeutics: Thinking About the Stock Price After Phase 2b Results for Aerosurf in RDS Are Released In July (WINT, $0.92)

Investment Thesis

Windtree is facing the ultimate of binary events when it releases topline results in July for its critical phase…
Read more…

Discovery Laboratories: Results for Aerosurf in Phase 2a Trial are Encouraging; Why Then Did the Stock Crash? (DSCO, Buy, $0.30)

Introduction

This report discusses the results of Discovery Laboratory’s first in human, phase 2a trial of Aerosurf. In writing this report,…
Read more…